Invest in these 2 ASX shares for a real shot at $1 million

Getting to seven figures is possible, but only if you give it a try. Check out these stocks that could take you there.

| More on:
A couple are happy sitting on their yacht.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sure, a million bucks no longer gets you an average house in Sydney.

But becoming a millionaire still has a ring to it, right?

The fact is you can still do plenty with a cool mill in the bank — not least retire on a comfortable lifestyle.

And I can tell you the dream is within reach if you invest in ASX shares and use the power of compounding.

Here's a hypothetical.

Let's say you have $50,000 saved to start a stock portfolio. For the sake of easy maths, let's say you add $500 to that each month.

If your stocks can pump out a compound annual growth rate (CAGR) of 15%, you will be a millionaire after 18 years.

That is, if you started at 30 years old, you can tell your boss where to go at 48.

Three growth shares that could have made you a million

Now, what sort of ASX shares could you achieve 15% CAGR?

Here are three examples that experts are currently urging punters to buy: Mader Group Ltd (ASX: MAD), Telix Pharmaceuticals Ltd (ASX: TLX) and Patriot Battery Metals Inc CDI (ASX: PMT).

Mader, which provides maintenance services for mining clients, listed on the ASX in October 2019 after issuing shares at $1 during its initial public offering (IPO).

The stock is now trading around $6.40, making it better than a six-bagger in about four years, or an eye-popping CAGR of 59%.

Telix Pharmaceuticals makes cancer diagnostic and treatment products. As some of its innovations have gone through testing, approvals and commercialisation, the stock price has rocketed 1,194% over the past five years.

That equates to a CAGR of 66.77%.

Patriot Battery Metals is in the business of finding sources of lithium.

The Canadian company sold its shares at 60 cents during its IPO, then floated in December last year. Patriot Battery Metals shares are now trading around the $1 mark, making it a 67% gain over 11 months.

Experts think there's more to come from the trio

Of course, past performance is never an indicator of the future. Therefore all this phenomenal performance doesn't mean that's how well they will do in the coming years.

But I present them to you to demonstrate that forming a portfolio with 15% CAGR to make a million is not an impossible task.

Also, experts still seem to be pretty bullish on all three of our examples, so at least they think they have a reasonable chance of continuing their bull run.

According to CMC Markets, four out of five analysts that cover Mader Group are rating it as a buy right now.

Meanwhile, all seven analysts that study Telix reckon it's an add, and same with all nine professionals that cover Patriot Battery Metals.

Should you invest $1,000 in Mader Group Limited right now?

Before you buy Mader Group Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Mader Group Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor Tony Yoo has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Mader Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Mader Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

Cheap Shares

3 oversold ASX shares begging to rebound

Analysts think these shares are too cheap to ignore at current levels.

Read more »

Person handing out $100 notes, symbolising ex-dividend date.
Dividend Investing

5 excellent ASX dividend shares to buy in May

Analysts think these shares are top picks for income investors next month.

Read more »

A person with a round-mouthed expression clutches a device screen and looks shocked and surprised.
Growth Shares

3 unstoppable ASX growth shares to buy and hold for the long term

Analysts have good things to say about these top stocks.

Read more »

ETF written on cubes sitting on piles of coins.
Dividend Investing

How can an ASX investment in the Vanguard Australian Shares High Yield ETF (VHY) boost my passive income?

ETFs can be fantastic hands-off sources of passive income.

Read more »

A young male builder with his arms crossed leans against a brick wall and smiles.
Dividend Investing

Building up income: 2 ASX dividend shares I believe are a buy

These stocks are delivering pleasing passive income growth.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

Is this a great opportunity to lock in big dividend yields for a second income?

Has the market selloff created an opportunity for income investors? Let's find out.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Dividend Investing

Don't miss out on these buy-rated ASX 200 dividend shares

Analysts are bullish on these names. Let's find out why.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

Top Australian stocks for a $7,000 investment today

These stocks are highly rated by analysts. Let's find out why.

Read more »